BNTC (STOCKS)
Benitec Biopharma Inc. Common Stock
$12.000000
+0.580000 (+5.08%)
Prev close: $11.420000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jerel A. Banks
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $412.60M
- Employees
- 19
- P/E (TTM)
- -12.28
- P/B (TTM)
- 2.09
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q2)
|
$-0.26 | $-0.23 | -0.0322 | -14.14% |
|
Sep 2025 (Q1)
|
$-0.22 | $-0.38 | +0.1557 | +41.44% |
|
Jun 2025 (Q4)
|
$-0.42 | $-0.30 | -0.1242 | -41.99% |
|
Mar 2025 (Q3)
|
$-0.24 | $-0.35 | +0.1148 | +32.36% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $4.24M |
| Operating Expenses | $43.20M |
| Research and Development | $18.05M |
| Other Operating Expenses | $25.15M |
| Operating Income/Loss | -$43.20M |
| Income/Loss From Continuing Operations After Tax | -$38.96M |
| Income/Loss From Continuing Operations Before Tax | -$38.96M |
| Net Income/Loss | -$38.96M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$38.96M |
| Net Income/Loss Available To Common Stockholders, Basic | -$38.96M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.93 |
| Diluted Earnings Per Share | -$0.93 |
| Basic Average Shares | 123,506,610 |
| Diluted Average Shares | 123,506,610 |
| Assets | $190.68M |
| Current Assets | $189.60M |
| Prepaid Expenses | $573.00K |
| Other Current Assets | $189.02M |
| Noncurrent Assets | $1.09M |
| Fixed Assets | $115.00K |
| Other Non-current Assets | $971.00K |
| Liabilities | $3.32M |
| Current Liabilities | $2.80M |
| Wages | $483.00K |
| Other Current Liabilities | $2.32M |
| Noncurrent Liabilities | $519.00K |
| Equity | $187.36M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $187.36M |
| Liabilities And Equity | $190.68M |
| Net Cash Flow From Operating Activities | -$18.43M |
| Net Cash Flow From Operating Activities, Continuing | -$18.43M |
| Net Cash Flow From Investing Activities | -$17.00K |
| Net Cash Flow From Investing Activities, Continuing | -$17.00K |
| Net Cash Flow From Financing Activities | $129.19M |
| Net Cash Flow From Financing Activities, Continuing | $129.19M |
| Net Cash Flow | $110.75M |
| Net Cash Flow, Continuing | $110.75M |
| Comprehensive Income/Loss | -$39.16M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$39.16M |
| Other Comprehensive Income/Loss | -$39.16M |
| Other Comprehensive Income/Loss Attributable To Parent | -$195.00K |